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Background/aim: CAIPIRINHA is a new technique in abdominal imaging. Pancreatic steatosis (PS) is a subject of increasing scientific
interest. The aim of this study was to investigate the efficacy of the isotropic 3D-VIBE- CAIPIRINHA -DIXON technique on a new
generation 3-tesla MR unit in the evaluation of PS.
Materials and methods: In this retrospective study, the imaging findings of 49 patients with PS and 41 control subjects were examined.
The pancreas-to-spleen ratio (PSR), pancreas-to-muscle ratio (PMR), and pancreatic signal intensity index (PSII) were defined as 3 new
parameters and these indexes were calculated from the in-phase/out of phase 3D-VIBE- CAIPIRINHA-DIXON images.
Results: The PSR, PMR, and PSII values were significantly different between the patient and control groups (P = 0.001, P = 0.009, P <
0.001, respectively). Statistically significant differences were observed between patient and control groups for ROI measurements of fatty
areas on these sequences/images: subtraction (in-out) (P < 0.001), T2W HASTE (P < 0.001), DIXON-fat (P < 0.001), fat-suppressed
T1W (P = 0.002), and subtraction (out-in) (P = 0.010).
Conclusion: Evaluation of PS with the 3D-VIBE-CAIPIRINHA-DIXON technique can be made rapidly and effectively.
Key words: Pancreas, magnetic resonance imaging, chemical shift imaging, MRI scans, steatosis

1. Introduction
Pancreatic steatosis (PS) was first defined by Ogilvie in a
cadaver study, with determination of relationships between
age and metabolic comorbidities such as atherosclerosis
and diabetes, and it became a subject in which interest has
not diminished [1–4]. It has been shown that fat in the
pancreas is related to the severity of pancreatitis, pancreatic
cancer, and postoperative pancreatic fistula [5–7]. In
recent literature, the clinical results related to PS have been
conflicting in publications regarding whether PS is related
to pancreatic endocrine or/and exocrine function [8,9].
Tahtacı et al. and Kromrey et al. suggested that pancreatic
exocrine impairment was associated with fatty pancreas via
magnetic resonance imaging and fecal elastase [8,9]. On
the other hand, Miyake et al. reported that fatty pancreas
was not associated with pancreatic exocrine impairment
but associated with endocrine impairment via computed
tomography (CT) [10]. There is no clinical and/or laboratory
biomarker of PS, although it can be assessed with radiological
modalities. However, PS is often overlooked in radiology

practice. Biopsy is the gold standard for exact evaluation
of the PS, but because of the location of the pancreas, the
complications risk, and sampling bias, radiological methods
are preferred for both evaluation and quantification [11].
There are some studies in the literature related to the
quantification of pancreatic fat content with MRI [11,12].
Techniques such as in phase-opposed phase, dual-echo,
or multiecho DIXON method, spectral-spatial excitation,
and spectroscopy are used in abdominal MR practice in
fat imaging [11–13]. Multiple applications of dual-echo
DIXON or multiecho DIXON methods are used for
improving fat saturation, quantification, and mapping
[11–14]. Quantitative techniques require more echoes
for achieving higher values of sensitivity, specificity, and
accuracy in detecting steatosis due to the limitations of
dual-echo DIXON method [14]. On the other hand, CT
is also used for quantification of fat in pancreas [10].
However, there is insufficient use of these methods in
routine daily practice to provide effective, objective, or
quantitative data.
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More recently, the use of the “controlled aliasing
in parallel imaging results in higher acceleration”
(CAIPIRINHA) method has been presented, which
allows the acquisition of isotropic, high-resolution, 3D
abdominal MRI data and reduces imaging time [15–18].
This parallel imaging method is a new technique offering
several advantages in abdomen imaging, such as reduced
artifacts and shorter acquisition time.
The aim of this study was to investigate the efficacy of
the isotropic 3D-VIBE-CAIPIRINHA-DIXON technique
on a 3-tesla device in noninvasive evaluation of PS.
2. Materials and methods
Our hospital patient information system (PACS)
was scanned to identify all the cases in which 3-tesla
noncontrast-material enhanced pancreas MRI was
administered during the 2-year period between 2015
and 2017. The images of those patients were retrieved
from the picture archiving and communication systems
(PACS) and evaluated. Cases diagnosed with PS on these
MR examinations (according to radiological MRI report)
formed the study group. Cases without PS from the same
MR protocol applied during the same period for various
reasons (e.g., cyst or mass identification), were accepted
as the control group. Cases were excluded if they had a
history of malignancy, pancreatic surgery, acute and
chronic pancreatitis, autoimmune/IgG4 pancreatitis,
pancreatic lesions, blood transfusion, hemochromatosis,
chemotherapy, or were diagnosed with iron overload
in their records. Approval for the study was granted by
the Local Ethics Committee (15.05.2018/24/10) and all
procedures were applied in accordance with the Helsinki
Declaration. Informed consent was waived because of the
retrospective nature of the study.
Two experienced radiologists (O.A. and U.K.)
evaluated the images for quality, and 9 cases were
excluded from the study due to technical reasons (such as
incomplete breath-holding or motion). Radiological MRI
reports and images were checked by O.A. for concordance
of radiological reports-images and preventing bias in
patient selection before evaluation by U.K. As a result, 49
patients (28 female, 21 male; mean age: 69 ± 8 years) with
PS and 41 control subjects (18 female, 23 male; mean age:
66 ± 9 years) were included in the study. The final study
population was 90 cases (mean age: 66 ± 9 years; range:
43–86 years; 46 female, 44 male).
2.1. MRI acquisitions
All cases were examined on a 3-tesla MR unit with a
48-channel system (Magnetom Skyra, Siemens Healthcare,
Germany) with 30-channel abdominal coil setup (with
18-channel body and 12-channel from the spine coils).
Patients were positioned headfirst and supine with the
coils fixed tightly. After the acquisition of localizer, T1 and

T2-weighted (W) routine (standard and vendor-optimized
noncontrast material enhanced 2D sequences) images
for pancreas imaging, pre and postcontrast 3D-VIBEGRAPPA, and 3D-VIBE-CAIPIRINHA-DIXON sequences
were obtained in each case. The 3D-VIBE-CAIPIRINHADIXON technique provided in-phase, opposed-phase,
fat, and water images, simultaneously. Dual-echo DIXON
chemical shift imaging was performed in acquisitions.
3D-VIBE-GRAPPA and 3D-VIBE-CAIPIRINHA-DIXON
sequences were performed in random order for all cases.
Details of the 3T MRI protocol used are given in Table 1.
2.2. Image evaluation
All images of the cases were evaluated randomly by an
experienced radiologist (U.K.), blinded to clinical history.
The findings mentioned below were analyzed, and related
grades/scores/measurements were recorded in the relevant
column of the study table. Some quantitative ratios (e.g.,
pancreatic signal intensity index, pancreas to spleen/
muscle ratios) were determined by the authors and these
ratios were calculated and recorded.
2.3. Qualitative analyses
PS was visually analyzed on the T1W fat-saturated (FS)
and T2W-HASTE images with a 3-point scale (grade
1: 0%–33%, grade 2: 34%–66%, grade 3: 67%–100%).
Pancreatic atrophy was assessed visually using a 4-point
scale (grade 0: none; grade 1: minimal; grade 2: moderate;
grade 3: prominent) taking the data of all the sequences
into consideration. Pancreas atrophy criteria were fat
accumulation in pancreas and a decrease in pancreatic
parenchyma size in visual radiological evaluation. The
localization of PS was evaluated using a 5-point scale
(grade 0: none; grade 1: diffuse; grade 2: head-neck;
grade 3: body; grade 4: tail) taking all the sequences into
consideration.
Fatty areas were assessed with a 3-point scale (hypointense: 0; iso-intense: 1; and hyper-intense: 2) for all
sequences. If fatty areas were observed as hyperintense on
in-phase images and hypointense on out-phase images,
this situation was accepted as suppression phenomenon
(chemical shift effect on DIXON images). This suppression
on in-phase and out-phase images of fatty regions was
assessed with a 4-point scale (absent: 0; minimal: 1;
moderate: 2; and prominent: 3).
The 3D-VIBE-CAIPIRINHA-DIXON data set
assessment was made visually by evaluating DIXON fat,
water, in-phase, and out-phase images together.
2.4. Quantitative analyses
For the determination of signal/noise ratios (SNRs)
on DIXON-subgroup and subtraction images, an
approximately 1 cm2 region of interest (ROI) was drawn
on the fatty area of the pancreas, not to go beyond the fatty
area (not including structures such as large vessels and the
main pancreatic canal) and the signal intensity (SI) of the
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Table 1. A 3 Tesla MRI protocol used for the study.
Sequences/parameters

T2-HASTE-FS

T2-HASTE

CAIPIRINHA

T1-VIBE

TR/TE (ms)

1000/95

1000/99

4.21/1.34

4/1.74

Slice thickness (mm)

5

5

1.5

2.2

FOV* (mm2)

380 × 297

400 × 336

450 × 366

400 × 338

Acquisition time (min.s)

1.25

0.57

0.14

0.13

NEX

1

1

1

1

Number of slices

38

26

96

64

Flip angle (°)

160

139

9

18

Imaging plane

Axial

Coronal

Coronal

Coronal

Distance factor (%)

20

10

20

20

PAT factor

2

3

6

3

PAT mode

GRAPPA

GRAPPA

CAIPIRINHA

GRAPPA

Voxel size (mm3)

1.2 × 1.2 × 5

1.2 × 1.3 × 4

1.4 × 1.4 × 1.5

1.3 × 1.3 × 2.2

Fat-saturation

+ (SPAIR)

–

–

+ (Q-fat-sat)

Base resolution

320

320

320

320

Matrix

203 × 320

320 × 320

256 × 192

256 × 192

NEX: number of excitations; FOV: field of view; PAT: parallel acquisition technique; GRAPPA: generalized auto
calibrating partially parallel acquisitions.

pancreatic tissue was determined (Figure 1). On the same
slice, a 1 cm2 ROI was placed on the noise area outside the
body, and the SNR was calculated. The contrast to noise
ratio (CNR) was calculated as the SNR measurement of
the target area value divided by the spleen SNR value.
The fat fraction % (FF%) value was calculated as a
percentage by dividing the SI value of the fatty area on the
fat images by the total SI value of the fatty areas on the
fat and water images (FF%) = (F/F + W)%. The adrenal
to spleen and adrenal signal intensity index formula
previously described by Savcı et al. for the evaluation of
adrenal masses were adapted to the pancreas [19]. These
ratios were calculated as follows:
Pancreas to spleen ratio (PSR) = ([SI pancreas/SI
spleen] on out-phase images / [SI pancreas /SI spleen] on
in-phase images – 1) × 100
Pancreas to muscle ratio (PMR) = ([SI pancreas/SI
muscle] on out-phase images / [SI pancreas /SI muscle] on
in-phase images – 1) × 100
Pancreatic signal intensity index (PSII) = (SI pancreas
in phase – SI pancreas out phase) / (SI pancreas in phase)
× 100
The quantitative measurements were obtained by a
single researcher (U.K.) blinded to the clinical data.
2.5. Statistical analyses
The conformity of variables to normal distribution was
assessed using the Shapiro–Wilk test. Variables were
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reported as median (minimum:maximum) values.
According to the normality test result, the Mann–Whitney
U test and Independent samples t test were used for
between-group comparisons. Categorical variables were
compared using the Chi-square test, Fisher–Freeman–
Halton test. The relationships between continuous and
discrete variables were examined using correlation analysis
and the Pearson/Spearman correlation coefficient was
calculated. ROC curve analysis was applied to determine
the FF% threshold values of each PS grade. The agreement
between sequences was determined using Cohen’s kappa
coefficient (κ). SPSS version 21 software (IBM Corp.,
Armonk, NY, USA) was used when performing statistical
analyses and the level of significance was set at α = 0.05.
3. Results
According to age and gender distribution, there was no
statistically significant difference between the groups (P >
0.05).
PS of varying degrees was observed in the majority
of cases in the patient group, and there was generally
minimal PS in control group cases (Table 2). A statistically
significant difference was determined between the groups
in respect to the presence of PS (P < 0.001, Table 2).
In general, the pancreatic fatty areas in the patient
group were seen as hypointense on out-phase images and
hyperintense on fat images; in the control group cases, the
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Figure 1. The measurements were made in the head-neck, body, and tail sections of the pancreas and spleen from a region of interest
(ROI) of approximately 1 cm2 on 3D-VIBE-CAIPIRINHA-DIXON data set (water, fat, in phase, out phase subgroup images).

fatty areas showed a heterogeneous signal intensity pattern
on out-phase images (Table 2). The difference between
the two groups in this respect was statistically significant
(P < 0.001, Table 2). In 88% of cases in the patient group,
suppression was observed on the in-phase and out-phase
images of the PS areas (Table 2).
Distribution of pancreatic atrophy grades and fatty
areas appearances of the patient group are given in Table
3. A statistically significant difference was determined
between the patient and control groups in respect of the
distribution of fatty replacement sites (P < 0.001, Table 3).
Pancreatic atrophy was determined in 25 (51%) cases
of the patient group and in 9 (22%) cases of the control
group (P = 0.001). In the control group, in subjects with
pancreatic atrophy, it was determined at a mild level (Table

3). The fatty replacement pattern was usually diffuse in
cases with minimal PS (Table 3).
In respect of PSR, PMR, and PSII variables, there
were statistically significant differences between the
groups (P = 0.001, P = 0.009, P < 0.001, Table 4). The ROI
measurements of the fatty areas on subtraction in-out
of phase, subtraction out-in phase, and fat images were
statistically significantly different between the patient and
control groups (P < 0.001, P = 0.01, P < 0.001, Table 4).
For ROI measurements of fatty areas, there were
statistically significant positive correlations between out
phase images and subtraction out-in, water images, or
PMR/PSR ratios for all patients (Table 5). In addition,
there were inverse or negative relationships between
fatty areas on out-phase images and subtraction in-out/
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Table 2. Comparison of morphological characteristics of fatty-areas between patient and control groups.
Pancreatic steatosis on HASTE images

Patient group

Controls

0%–33% (grade 1)

15 (27.8%)

39 (95.1%)

34%–66% (grade 2)

22 (44.9%)

2 (4.9%)

67%–100% (grade 3)

12 (24.5%)

0

Pancreatic steatosis on T1WFS images

Patient group

Controls

0%–33% (grade 1)

30 (61.2%)

41 (100%)

34%–66% (grade 2)

16 (32.7%)

0

67%–100% (grade 3)

3 (6.1%)

0

3D-VIBE-CAIPIRINHA-DIXON data set assessment

Patient group

Controls

0%–33% (grade 1)

24 (49%)

41 (100%)

34%–66% (grade 2)

19 (38.8%)

0

67%–100% (grade 3)

6 (12.2%)

0

Appearance of fatty-areas on fat images

Patient group

Controls

Isointense (score 1)

5 (10.2%)

25 (61%)

Hyperintense (score 2)

44 (89.8%)

16 (39%)

Suppression on out-phase images

Patient group

Controls

Absent (score 0)

6 (12.2%)

26 (63.4%)

Minimal (score 1)

17 (34.7%)

11 (26.8%)

Moderate (score 2)

18 (36.7%)

4 (9.8%)

Prominent (score 3)

8 (16.3%)

0

Appearance of fatty-areas on out-phase images

Patient group

Controls

Hypointense (score 0)

43 (87.8%)

15 (36.6%)

Isointense (score 1)

0

1 (2.4%)

Hyperintense (score 2)

6 (12.2%)

25 (61%)

P value
<0.001a
P value
<0.001a
P value
<0.001a
P value
<0.001a
P value

<0.001b

P value
<0.001b

Pearson chi-square test; bFisher–Freeman–Halton test.

a

Table 3. Pancreatic atrophy and fatty replacement areas comparisons of the
patient and control groups. Data were given as number and percentage (%).

b
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Pancreatic atrophy

Patient group

Controls

None

24 (49%)

32 (78%)

Minimal

13 (26.5%)

9 (22%)

Moderate

10 (20.4%)

0

Prominent

2 (4.1%)

0

Fatty replacement sites

Patient group

Controls

Diffuse

45 (91.84%)

9 (21.95%)

Only head-neck

0

0

Only body

3 (6.12%)

4 (9.76%)

Only tail

1 (2.04%)

3 (7.32%)

Fisher–Freeman–Halton test.

P value

0.001b

P value

<0.001b

KOÇ et al. / Turk J Med Sci
fat images, or PSII values (Table 5). Also, there are many
negative or positive correlations for many study parameters
between in-phase and out-phase data for fatty-region ROI
measurements (Table 5).
FF% cut-off value for the diagnosis of PS with given
sensitivities and specificities was determined to be 25%

(sensitivity: 92.1%; specificity: 89.2%; AUC: 0.94; P <
0.001; 95% CI 0.88–1.00) (Figure 2). FF% value > 48.6%
was determined as the cut-off value for the diagnosis of
grade 2 PS (sensitivity: 100%; specificity: 82%; AUC: 0.89;
P < 0.001; 95% CI 0.82–0.97) (Figure 3). ROC analyses
showed that FF% value > 64% was the diagnostic cut-off

Table 4. Quantitative study parameters of the patient and control groups.
Parameters

Patients (n = 49)

Controls (n = 41)

P value

Median (minimum : maximum)

Median (minimum : maximum)

PSR

–45.77 (–84.38 : 177.86)

–21.08(–66.85 : 15.63)

0.001c

PMR

–25.49(–76.11 : 175.33)

–2.87(–56.13 : 128.79)

0.009c

PSII

49.40(–167.86 : 75.61)

22.08 (1.12 : 69.94)

<0.001c

Fatty areas SI on subtraction out-in

3 (0 : 12)

4 (0 : 45)

0.010c

Fatty areas SI on subtraction in-out

172 (32 : 344)

82 (19 : 272)

<0.001d

Fatty areas SI on fat images

177.81 (23.44 : 327.83)

55.70 (13.95 : 99.08)

<0.001c

CNR of fatty areas on fat images

8.11 (0.52 : 22.33)

2.06 (0.42 : 6.25)

<0.001c

SNR of fatty areas on fat images

19.04 (0.36 : 54.53)

9.61 (1.62 : 38.85)

0.001c

Fat fraction via SI

57.34 (8.50 : 83.82)

17.83 (6.45 : 31.96)

<0.001c

Fat fraction via SNR

38.83 (2.11 : 73.41)

10.23 (3.02 : 43.29)

<0.001c

Fat fraction via CNR

91.64 (31.14 : 98.67)

65.73 (31.28 : 85.83)

<0.001c

Spleen intensity on fat images

22.62 (12.54 : 72.73)

24.24 (11.74 : 95.95)

0.916c

Spleen signal intensity index

6.51 (–99.57 : 35.10)

5.52 (–64.49 : 31.03)

0.613c

Mann–Whitney U test; dIndependent samples t test.

c

Table 5. Relationships between ROI values of fatty areas and other study parameters.

Parameters

Fatty areas on
in-phase images

Fatty areas on
out-phase images

r

P

r

P

Fatty areas on subtraction out-in

–0.04

0.693

0.26

Fatty areas on subtraction in-out

f

0.20

ROI values of fatty areas on fat images

0.35e

e

0.013

e

0.055

f

–0.48

<0.001

0.002

–0.51e

<0.001

ROI values of fatty areas on water images

f

0.26

0.024

f

0.72

<0.001

PSR

0.14e

0.199

0.62e

<0.001

PMR

0.08

0.433

0.45

<0.001

PSII

–0.06e

0.563

–0.60e

<0.001

CNR of fatty areas on fat images

0.34

0.003

–0.37

0.001

SNR of fatty areas on fat images

e

0.11

0.365

–0.32

0.005

Fat fraction via signal intensity

0.16e

0.178

–0.59e

<0.001

Fat fraction via SNR

e

0.10

0.414

e

–0.57

<0.001

Fat fraction via CNR

0.29e

0.013

–0.47e

<0.001

e

e

e

e
e

Spearman correlation coefficient; fPearson correlation coefficient.

e
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Figure 2. Receiver-operator characteristic (ROC) curves for the diagnosis of PS
between patient and control group using the 3D-VIBE-CAIPIRINHA-DIXON data
set. The area under the curve (AUC) for 3D-VIBE-CAIPIRINHA-DIXON data set is
0.94 (95% CI: 0.88–1.00) with P < 0.001.

value for grade 3 PS (sensitivity: 100%; specificity: 90%;
AUC: 0.97; P = 0.002; 95% CI 0.92–1.00) (Figure 4).
There was moderate agreement between 3D-VIBECAIPIRINHA-DIXON data and HASTE or T1WFS
(0.623, 0.687, respectively; P < 0.001). Also, there was
minimal agreement between HASTE and T1WFS (0.392;
P < 0.001) images.
4. Discussion
The point of motivation for this study was to evaluate
the efficacy of the 3D-VIBE-CAIPIRINHA-DIXON
technique in the cases of pancreatic steatosis. The main
reasons for this preference were the consideration
of homogenous fat-suppression with this technique
and fewer motion artifacts due to a faster acquisition,
leading to improved delineation of the pancreas on 3D
subgroup images (especially fat, water, and subtraction
images) as highlighted in the literature. There are very
few studies in the literature related to CAIPIRINHA
and MR evaluation of PS [20–23]. The CAIPIRINHA
technique is relatively new and has started to be used in
various clinical protocols in abdominal imaging [22,23].
The use of the CAIPIRINHA together with the DIXON
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technique, which is a chemical shift-based fat saturation
technique, has been reported in literature as an element
increasing image quality in isotropic-3D abdominal
imaging [18]. CAIPIRINHA enables the acquisition of
satisfactory image quality during the time of holding a
single breath, thereby overcoming the long scanning time,
which is the most significant disadvantage of the DIXON
technique [18]. In a recent study, it was reported that
CAIPIRINHA-DIXON provided high temporal resolution
without loss of spatial resolution [22]. Furthermore, the
use of CAIPIRINHA together with the DIXON technique
allows more homogenous fat suppression on isotropic 3D
imaging. Consequently, 3D-VIBE-CAIPIRINHA-DIXON
increases contrast between the pancreas and surrounding
peripancreatic tissues. The pancreas can be evaluated in
multiple planes and at high CNR with a single acquisition
by 3D-VIBE-CAIPIRINHA-DIXON [18].
When the clinical reflection of PS is examined, there
are publications that report endocrine and exocrine
insufficiency or disorders, increased severity of pancreatitis,
development of pancreatic cancer, and postoperative
pancreatic fistula on the basis of fatty pancreas [5–7,11,24–

KOÇ et al. / Turk J Med Sci

Figure 3. Receiver-operator characteristic (ROC) curves for the diagnosis of grade 2
steatosis using the 3D-VIBE-CAIPIRINHA-DIXON data set. The area under the curve
(AUC) for 3D-VIBE-CAIPIRINHA-DIXON data set is 0.89 (95% CI: 0.82–0.97) with
P < 0.001.

26]. CT is one of the tools for quantification of fat in the
pancreas [10]. Pancreas to spleen density ratio (P/S) via
CT is the current indicator of interest for the prediction
of postoperative pancreatic fistula development before
pancreatoduodenectomy procedure and endocrine and
exocrine insufficiency or disorders [10,27,28]. Fukie et al.
reported that MR-based pancreatic fat quantification was
superior to CT-based quantification for estimating the
probability of pancreatic cancer [29].
Acquisition time of conventional out-phase/in-phase
imaging without acceleration is approximately 60 s. In
this study, PS was evaluated on 3D-VIBE-CAIPIRINHADIXON images obtained within a single breath (acquisition
time of 14 s). The SNR and CNR ratios of the fatty areas
were calculated, and to be able to evaluate PS quantitatively,
the new parameters of PSR, PMR, and PSII were defined.
For fatty areas, there was a significant negative correlation
between SI values of 3D-VIBE-CAIPIRINHA-DIXON out
of phase images and SI values of 3D-VIBE-CAIPIRINHADIXON fat images, PSII ratio, and FF%. This negative
correlation can be considered to be due to loss of signal
seen in out of phase imaging in the areas of steatosis.
In addition, in the current study, a significant positive
correlation was determined between PSR/PMR values

and signal intensities of fatty areas on subtraction (out-in
phase) images. According to the above-mentioned results,
PSR, PMR, and/or PSII ratios can be useful for quick
and quantitative assessment and follow-up of PS and the
pancreas. In the preoperative planning or follow-up of
PS or pancreatic atrophy, the 3D-VIBE-CAIPIRINHADIXON and the parameters derived using this technique
can be used within a short time and free of radiation.
Consistent with previous findings in literature,
statistically significant differences were determined
between the patient and control groups with respect to many
MR parameters for PS evaluation [23,30]. Ghasabeh et al.
reported that dual-echo and multiecho DIXON methods
revealed moderate and good correlations with each other
and magnetic resonance spectroscopy (MRS) related to
fat measurements in liver and pancreas [14]. In our study,
we used a dual-echo DIXON method for quantification
of fat with parallel imaging technique, CAIPIRINHA.
For the detection of pancreatic fat, FF% can be calculated
using signal intensities (SI) from out-phase and in-phase
images via chemical shift techniques [21]. The results of
this study showed a good correlation between the FF%
values calculated using DIXON fat and water subgroup
images and the grading on the other images. In the FF%
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Figure 4. Receiver-operator characteristic (ROC) curves for the diagnosis of grade 3
steatosis using 3D-VIBE-CAIPIRINHA-DIXON data set. The area under the curve
(AUC) for 3D-VIBE-CAIPIRINHA-DIXON data set is 0.97 (95% CI: 0.92–1.00) with
P = 0.002.

analyses, if the cut-off value was selected as 24.69%, FF%
sensitivity was 91.2% and specificity was 80.5% (based on
final decisions by 3D-VIBE-CAIPIRINHA-DIXON data
set). In general, as FF% values increase, the sensitivity
decreases and the specificity increases (or vice versa).
The parameter commonly used in the literature [19]
for fat detection, such as signal intensity ROI values
on out phase images and the findings in the routine
imaging sequences, show a good correlation with the PSII
parameter, which has been defined in this study for the
first time in literature and was derived from the image data
set obtained using this technique. This parameter can also
be used as a reliable indicator for fat measurements.
T2W fast-spin echo, HASTE, and/or T1W sequences
with and without fat-saturation are generally used in routine
pancreatic imaging [31]. Homogenous fat suppression for
these techniques or pancreatic imaging are needed. In
general, conventional fat-saturation techniques provide
heterogeneous fat, although the long echo train length in
the T2W HASTE sequence reduces spatial resolution, SNR,
and CNR parameters [32–34]. This leads to limitations
in the evaluation [33–34], and these limitations can be
overcome with the DIXON technique [18].
The results of this study demonstrated differences
between the data obtained from the routine sequences and
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the 3D-VIBE-CAIPIRINHA-DIXON data set. The study
results showed that the nonfat saturated T2W HASTE
technique caused overestimation according to 3D-VIBECAIPIRINHA-DIXON in PS evaluation, whereas the
T1W-FS resulted in underestimation according to
3D-VIBE-CAIPIRINHA-DIXON. When the agreement
between the sequences was examined, there was moderate
agreement between the 3D-VIBE-CAIPIRINHA-DIXON
data set assessment and HASTE and T1WFS, and minimal
agreement between HASTE and T1WFS. These findings
reveal the nonconformity of evaluating a single sequence
when evaluating the PS. 3D-VIBE-CAIPIRINHA-DIXON
increases the confidence of the evaluator as well as reducing
acquisition time. 3D-VIBE-CAIPIRINHA-DIXON allows
us a more robust pancreatic assessment with the benefits
of DIXON, which allows homogenous fat suppression,
and CAIPIRINHA, which makes a positive contribution
to CNR, and provides 3D isotropic imaging.
In an MRI-based study by Wong et al., PS prevalence
was determined as 16% in healthy subjects and PS seen at
up to 10.4% was accepted as a normal condition, thereby
establishing a cutoff value of 10.4% for PS [13]. In the
current study, the vast majority of the control cases were
determined as grade 1 (0%–33%), similar to the literature.
A previous study determined minimal (grade 1) PS in
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cases determined with grade 1 nonalcoholic fatty liver
disease [20]. That minimal PS was observed in the majority
of our control group and suppression was observed at
a rate of 37% (15/41) on the out of phase images. This
can be explained by the mean age of the control group
being relatively high and that therefore a certain level
of fat content would be found in the normal pancreas.
A positive correlation between age and PS is known to
exit [2,3]. However, in the patient group, grade 1 PS was
determined at 49% and grades 2 and 3 were determined
at 51%. Minimal, moderate, and advanced suppression
was determined on the out-phase images in 87.8% of the
patient group, which was statistically significantly higher
compared to the control group (P < 0.001).
When evaluating the distribution of fatty areas, most
of the current cases were seen to have diffuse type PS. This
finding was consistent with the literature data [20,21].
Another finding of the study was the determination of
pancreatic atrophy at 22% (9/41) in the control group,
and at 51% (25/49) in the patient group (P = 0.001). These
results are evidence of a relationship between PS and
pancreatic atrophy.
Savcı et al. argued that the suppression effect on the
in-phase and out-phase images is a sign of intracellular fat
accumulation [19]. Our study revealed that suppression
was observed in fatty areas on the in-phase and out-phase
images in 88% of cases with PS. This result suggests that the
cause of PS is mostly due to intracellular fat accumulation.
According to our knowledge, this information is not yet
available in the radiology or imaging literature.

There were some limitations to this study. First,
no comparison was made of the MR findings with the
histopathological evaluation, which is the gold standard.
On the other hand, magnetic resonance spectroscopy
(MRS) shows a good correlation with mDIXON for
assessment of hepatic and pancreatic fat fraction [29].
MRS has been known as the second most accepted
standard approach to quantification of fat noninvasively
but is challenging due to the size of the pancreas, artefacts
such as motion, several technical limitations such as
software requirements, and amount of time required [14].
Proton density fat fraction (PDFF) is a commonly used
technique for direct quantification of fat in abdominal
imaging [30]. The retrospective nature of the study and the
lack of PDFF application when images were obtained led
to the ROI measurements of pancreatic signal intensity fat
fraction. The reliability of multiecho, dual-echo DIXON
ROI measurements of pancreatic signal intensity fat
fraction can be tested via PDFF technique or MRS. Inter/
intraobserver agreement was not evaluated, and the study
population was relatively low. There is a need for further
studies with larger patient series, taking these points into
consideration.
In conclusion, in our study, 3D-VIBE-CAIPIRINHADIXON was preferred for accurate and fast assessment of
PS. PSII, a newly described parameter, can be used as a
quantitative indicator in the evaluation and follow-up of
PS. Also, the cause of PS is mostly due to intracellular fat
accumulation. This study can be considered of value as
a preliminary study that can be of guidance for further
clinical and radiological studies.
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